RGNT
HEALTHCARERegentis Biomaterials Ltd
Live · AMEX · May 9, Close
What's Moving RGNT Today?
No stock-specific AI insight has been generated for RGNT yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Trading
RGNT News
16 articles- Regentis Implements Strategy for Commercial Deployment of GelrinC(R) in Europe Through Collaboration with Humanitas Hospital and Leading Cartilage Repair Expert Prof. Elizaveta KonYahoo Finance·Apr 16, 2026
- Regentis Biomaterials Develops and Patents New Solvent-Free Manufacturing Process That Increases GelrinC Production Yield by 400%Yahoo Finance·Mar 17, 2026
- Regentis Biomaterials Reports 2025 Financial Results and Provides Business UpdateYahoo Finance·Feb 24, 2026
- Regentis Biomaterials (RGNT) Appoints New CFO/CBO as GelrinC Nears Commercial LaunchYahoo Finance·Feb 24, 2026
- Regentis Biomaterials Appoints Dr. Galit Reske as Chief Medical Officer: Brings Strong Track Record of Success in Cartilage RepairYahoo Finance·Feb 19, 2026
- Regentis Expands its European Clinical Site Network to Support its Commercial and Clinical ProgramsYahoo Finance·Feb 17, 2026
- Regentis Biomaterials Appoints Ori Gon as Chief Financial Officer and Chief Business Officer as GelrinC Progresses Towards Commercial Launch in Europe and Advances in U.S. Phase III FDA TrialYahoo Finance·Feb 4, 2026
- Regentis Expanding Pivotal Phase III GelrinC Clinical Site Network: Adding Several Leading Orthopedic Centers Across the U.S.Yahoo Finance·Jan 29, 2026
- Regentis' GelrinC Demonstrates Breakthrough in Regenerating Native-Like Cartilage Structure in Knee Repair on MRI Results Confirmed Using a Validated, Regulator-Accepted MethodYahoo Finance·Jan 20, 2026
- Regentis' GelrinC Establishes Long-Term Durability of Cartilage Repair Through Quantitative MOCART EvaluationYahoo Finance·Jan 6, 2026
- Regentis Biomaterials Granted New U.S. Patent for its Off-the-Shelf Regenerative Cartilage Repair Product GelrinCYahoo Finance·Dec 18, 2025
- Regentis Biomaterials Commences Trading on NYSE: Set to Transform Cartilage Repair Market with Off-the-Shelf Regenerative ProductYahoo Finance·Dec 8, 2025
- Regentis Biomaterials Ltd. Announces Closing of Initial Public OfferingYahoo Finance·Dec 5, 2025
- Sector Update: Health Care Stocks Slide Late AfternoonYahoo Finance·Dec 4, 2025
- Sector Update: Health Care Stocks Softer in Afternoon TradingYahoo Finance·Dec 4, 2025
- Regentis Biomaterials Ltd. Announces Pricing of Initial Public OfferingYahoo Finance·Dec 4, 2025
All 16 articles loaded
Price Data
Fundamentals
Trading
About Regentis Biomaterials Ltd
Regent Assisted Living Inc. is a premier provider of high-quality assisted living and memory care services, dedicated to improving the lives of seniors through personalized care and supportive environments. With an extensive portfolio of facilities across the country, Regent stands out for its commitment to modern amenities and the professionalism of its compassionate staff. The company leverages innovative care models and fosters community involvement to elevate its offerings in the senior living market. As the need for senior care solutions grows, Regent's strategic expansion positions it as an attractive investment opportunity for institutional investors focused on growth in the healthcare sector.